- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06090097
Knee Biofeedback Rehabilitation Through Game Therapy (KneeBRIGHT)
October 13, 2023 updated by: Barron Associates, Inc.
Knee-Biofeedback Rehabilitation Interface for Game-based Home Therapy
The goal of this study is to learn about the effect of video-game based rehabilitation exercise for patients with knee osteoarthritis.
The main question the study aims to answer is: do patients who exercise with the game have better functional outcomes and engagement compared to patients who do conventional exercise?
Participants will complete 10 weeks of physical therapy exercise sessions that focus on quadriceps strengthening.
Two sessions per week will be conducted in the clinic, and one session will be conducted at home each week.
The interventional group will conduct all exercises using the KneeBRIGHT EMG sensors and game software.
The control group will conduct all exercises following a standard physical therapy regimen.
Researchers will compare knee function and engagement between the group who uses the game, and the group who does conventional exercise.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
The KneeBRIGHT game system will be evaluated in a 10-week single-blinded randomized controlled trial.
The goals of this study are to: (1) assess improvements in functional outcomes following an exercise regimen conducted by KneeBRIGHT compared to conventional exercise; and (2) evaluate patient engagement during unsupervised, home-based exercises with and without the KneeBRIGHT software.
Over the course of the study period, the knee OA participants will conduct physical therapy sessions with the physical therapist (PT) who enrolled them.
The exercise regimen will implement each PT's standard of care, consisting of two weekly clinic sessions and one weekly home exercise session, for 10 weeks.
Knee OA participants will be randomly assigned (via block randomization for each PT) to use either the KneeBRIGHT system for both clinic and home exercise, or to receive standard care with conventional exercise routines.
Participants will conduct functional exercise assessments on study intake and again on study completion.
Participants will also complete questionnaires focused on exercise engagement on study completion.
Study Type
Interventional
Enrollment (Estimated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Eileen Krepkovich, MS
- Phone Number: 123 4349731215
- Email: krepkovich@barronassociates.com
Study Locations
-
-
North Carolina
-
Chapel Hill, North Carolina, United States, 27599
- University of North Carolina Chapel Hill
-
Contact:
- Joe M Hart, PhD
- Phone Number: 919-966-9166
- Email: joe_hart@med.unc.edu
-
Principal Investigator:
- Joe M Hart, PhD
-
Sub-Investigator:
- Carla Hill, DPT
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- diagnosis via x-ray, with a score of at least 2 (out of 4) on the Kellgren-Lawrence OA scoring system; independent ambulation without assistive device
Exclusion Criteria:
- individuals who have psychiatric or cognitive impairment (e.g., dementia) that interferes with their ability to follow instructions or provide voluntary consent; symptomatic spine, hip, ankle, or foot disease other than OA that would interfere with assessment of the knee.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: KneeBRIGHT Group
The interventional group will conduct all exercises during the 10-week therapy regimen using the KneeBRIGHT electromyogram sensors and game software.
|
The KneeBRIGHT system includes electromyogram sensors and video game software that leads participants through physical therapy exercise.
|
Active Comparator: Control Group
The control group will conduct all exercises following a standard physical therapy regimen.
|
The control group will complete a 10-week regimen of conventional PT exercise
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Knee Osteoarthritis Outcome Score
Time Frame: After 10 weeks (study completion)
|
A multi-dimensional assessment that classifies knee outcomes into five categories: pain, symptoms, activities of daily living (ADL), sport, and quality of life
|
After 10 weeks (study completion)
|
Timed get-up-and-go score
Time Frame: After 10 weeks (study completion)
|
In the timed up and go (TUG) test, subjects are asked to rise from a standard armchair, walk to a marker 3 m away, turn, walk back, and sit down again.
|
After 10 weeks (study completion)
|
6-minute walk test
Time Frame: After 10 weeks (study completion)
|
The six-minute walk test (6MWT) measures the distance an individual is able to walk over a total of six minutes on a hard, flat surface.
|
After 10 weeks (study completion)
|
Quadriceps strength
Time Frame: After 10 weeks (study completion)
|
Quadriceps strength will be measured by recording isokinetic knee extension torque as measured by a dynamometer
|
After 10 weeks (study completion)
|
Patient Activation Model Scores
Time Frame: After 10 weeks (study completion)
|
The Patient Activation Model (PAM) is an established, highly reliable, questionnaire that reflects a developmental model of patient engagement with their healthcare regimens
|
After 10 weeks (study completion)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient technology acceptance
Time Frame: After 10 weeks (study completion)
|
Participants will complete a questionnaire, designed based on the established Technology Acceptance Model to assess their level of technology acceptance.
|
After 10 weeks (study completion)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient home exercise adherence
Time Frame: After 10 weeks (study completion)
|
The KneeBRIGHT software will log the exercises completed at home; these logs will report number of exercises conducted, level of resistance, and timestamps for the sessions.
Control group participants will log home exercises using a written checklist of exercises
|
After 10 weeks (study completion)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Eileen Krepkovich, MS, Barron Associates
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
January 1, 2024
Primary Completion (Estimated)
November 1, 2024
Study Completion (Estimated)
December 1, 2024
Study Registration Dates
First Submitted
October 13, 2023
First Submitted That Met QC Criteria
October 13, 2023
First Posted (Actual)
October 19, 2023
Study Record Updates
Last Update Posted (Actual)
October 19, 2023
Last Update Submitted That Met QC Criteria
October 13, 2023
Last Verified
October 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KneeBRIGHT2B
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Knee Osteoarthritis
-
LifeBridge HealthMicroPort Orthopedics Inc.; Rubin Institute for Advanced OrthopedicsRecruitingKnee Osteoarthritis | Osteoarthritis, Knee | Knee Pain Chronic | Arthropathy of Knee Joint | Knee Disease | Osteoarthritis Knees Both | Osteoarthritis Knee Left | Osteoarthritis Knee RightUnited States
-
University Hospital, Clermont-FerrandSanofiCompletedKnee Osteoarthritis (Knee OA)France
-
Joseph E. BroylesCompletedDegenerative Lesion of Articular Cartilage of Knee | Degeneration; Articular Cartilage, Knee | Unilateral Primary Osteoarthritis of Knee | Osteoarthritis Knee
-
The Hong Kong Polytechnic UniversityCompleted
-
Federal University of São PauloCompletedKNEE OSTEOARTHRITISBrazil
-
Jiangsu XinChen-Techfields Pharma Co., LTD.Completed
-
Tianjin XinChen-Techfields Pharma Co., LTD.Completed
-
Eun Jung KimMinistry of Health & Welfare, Korea; Semyung UniversityUnknownOsteoarthritis KneeKorea, Republic of
-
Thammasat UniversityCompletedPrimary Knee OsteoarthritisThailand
-
Galderma R&DCompletedUnilateral Knee OsteoarthritisUnited Kingdom
Clinical Trials on KneeBRIGHT System
-
University of VirginiaNational Institutes of Health (NIH); Barron Associates, Inc.CompletedOsteo Arthritis KneeUnited States
-
ResMedCompleted
-
Federal University of São PauloCompletedAdverse Reaction to Systemic AgentsBrazil
-
KineticureCompletedOsteoarthritis | Knee PainUnited States
-
Smith & Nephew, Inc.CompletedDiabetic Foot Ulcers | Venous Leg UlcersUnited States, Canada
-
Molnlycke Health Care ABCompletedEvaluation of Negative Pressure Wound Therapy in the Treatment of DFUs Incl. Post Amputation Wounds.Diabetes | Foot UlcersUnited Kingdom
-
Zahedan University of Medical SciencesUnknownPain, Postoperative Pain Pathologic Processes Postoperative Complications Signs and Symptoms
-
University of British ColumbiaNot yet recruitingPersistent Developmental Stutter | Childhood-Onset Fluency Disorder (Stuttering)
-
National Institute of Neurological Disorders and...Recruiting